Presentation TCT 2012

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

Presenter: Miltiadis Papalexandris, Hubertus Degen, Carsten Stoepel, Thomas Lickfeld, Thorsten Schneider, Carlos Freitas, Michael Haude

January 03, 2012

REGISTER for free or LOG IN to view this content

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

CAD Pharma

Presentation

TCT 2012

Up Next

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu

January 03, 2012

More slides +

Presentation TCT 2012

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Presenter: Alfonso Ielasi

January 03, 2012

Presentation TCT 2012

Clinical Outcomes Of Primary Percutaneous Coronary Intervention In Elderly Versus Younger Patients Presenting with Acute Myocardial Infarction (From the KAMIR)

Presenter: Jin Hee Choi

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.